Rikkunshito increases appetite by enhancing gastrointestinal and incretin hormone levels in patients who underwent pylorus-preserving pancreaticoduodenectomy: A retrospective study

doi:10.4240/wjgs.v15.i5.871

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3143)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

112

WORD

HTML

1305

Figures (1-6)

189

Tables (1-1)

209

Sum=1844

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

164

Download

626

Sum=790

Publishing Process of This Article

Item

Count

Browse

137

Download

372

Sum=509

May 27, 2023 (publication date) through Dec 18, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. May 27, 2023; 15(5): 871-881
Published online May 27, 2023. doi: 10.4240/wjgs.v15.i5.871

Table 1 Clinicopathological characteristics

Variable		TJ-43(−), n = 20	TJ-43(+), n = 21	Pvalue
Age in yr		67 ± 7.0	66 ± 7.7	0.962
Sex, n (%)	Male	10 (50)	14 (67)	0.199
Sex, n (%)	Female	10 (50)	7 (33)
Disease, n (%)	Pancreas Ca. (Ph)	7 (35)	8 (38)
	IPMC	2 (10)	2 (10)
	IPMA	2 (10)	1 (5)
	CBD Ca.	5 (25)	5 (24)
	Vater Ca.	3 (15)	4 (19)
	Panaceas-NET	1 (5)	0 (0)
	GB Ca.	0 (0)	1 (5)
UICC Tumor stage: Pancreas Ca. (0/I/IIA/IIB); Other Ca. (0/I/II/III)	Pancreas Ca. (Ph)	(0/0/1/6)	(0/0/3/5)
	IPMC	(1/0/1/0)	(0/0/1/1)
	IPMA	N/A	N/A
	CBD Ca.	(0/1/4/0)	(0/3/2/0)
	Vater Ca.	(0/1/2/0)	(0/2/2/0)
	P-NET	(0/1/0/0)	N/A
	GB Ca.	N/A	(0/0/1/0)
Tumor differentiation (well/mod/poor)	Pancreas Ca. (Ph)	(3/2/2)	(1/6/1)
	IPMC	(0/2/0)	(1/0/1)
	IPMA	N/A	N/A
	CBD Ca.	(0/5/0)	(2/2/1)
	Vater Ca.	(2/1/0)	(1/3/0)
	P-NET	N/A	N/A
	GB Ca.	N/A	(0/1/0)
Time of operation in min		500 ± 56	509 ± 0.72	0.299
Blood loss in mL		692 ± 0.54	959 ± 0.66	0.182
HbA1c, %		5.6 ± 2.2	5.7 ± 2.3	0.892
Tumor markers	CEA in ng/mL	3.1 ± 1.3	3.7 ± 1.1	0.872
Tumor markers	CA19-9 in U/mL	455 ± 23	451 ± 29
DGE, %		25	19	0.773
POPF, n (%)	Grade A	15 (75)	16 (76)
POPF, n (%)	Grades B and C	5 (25)	5 (24)	0.886
Post-operative pneumonia, n (%)		1 (5)	1 (4.8)	0.889

UICC: Union for International Cancer Control; Ph: Pancreas head; IPMC: Intraductal papillary mucinous carcinoma; IPMA: Intraductal papillary mucinous adenoma; CBD: Common bile duct; Ca: carcinoma; NET: Neuroendocrine tumor; GB: Gall bladder; Hb: Hemoglobin; DGE: Delayed gastric empty; POPF: Post-operative pancreatic fistula; TJ-43: Rikkunshito; TJ-43(-): Patients without TJ-43 treatment; TJ-43(+): Patients with TJ-43 treatment; N/A: No application.

Citation: Kono H, Hosomura N, Amemiya H, Shoda K, Furuya S, Akaike H, Kawaguchi Y, Kawaida H, Ichikawa D. Rikkunshito increases appetite by enhancing gastrointestinal and incretin hormone levels in patients who underwent pylorus-preserving pancreaticoduodenectomy: A retrospective study. World J Gastrointest Surg 2023; 15(5): 871-881
URL: https://www.wjgnet.com/1948-9366/full/v15/i5/871.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i5.871